intronic variant
Showing 1 - 25 of 599
Cystic Fibrosis, CFTR Gene Mutation Trial in Montpellier (Nasal cells sampling, Rectal biopsy sampling)
Recruiting
- Cystic Fibrosis
- CFTR Gene Mutation
- Nasal cells sampling
- Rectal biopsy sampling
-
Montpellier, FranceMontpellier University Hospital
Mar 31, 2022
Fibromuscular Dysplasia Trial in Brussels (Genetic dissection of Fibromuscular Dysplasia, Search for diagnostic and prognostic
Recruiting
- Fibromuscular Dysplasia
- Genetic dissection of Fibromuscular Dysplasia
- Search for diagnostic and prognostic biomarkers of Fibromuscular Dysplasia
-
Brussels, BelgiumCliniques Universitaires Saint-Luc
May 4, 2022
United States Hypophosphatasia Molecular Research Center
Recruiting
- Hypophosphatasia
- Whole Genome Sequencing
-
Kansas City, MissouriChildren's Mercy Hospital
Sep 22, 2022
Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney Trial in
Not yet recruiting
- Atypical Hemolytic Uremic Syndrome
- +3 more
- Skin biopsy
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Aug 9, 2023
ALS, FTD Trial in Worldwide (WVE-004, Placebo)
Active, not recruiting
- ALS
- FTD
- WVE-004
- Placebo
-
North Ryde, New South Wales, Australia
- +16 more
Feb 2, 2023
Biomarker Research in Inherited Movement Disorders
Recruiting
- Inherited Movement Disorders
- +2 more
- Clinical follow-up
-
Paris, FranceHôpital Pitié Salpetrière
Aug 11, 2022
COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)
Recruiting
- COVID-19 Pandemic
- +3 more
- mRNA-1273.214 Vaccine
- +2 more
-
Ramat-Gan, IsraelSheba Medical Center
Oct 26, 2022
Patients With Cognitive and Behavioral Disorders
Not yet recruiting
- Behavioral Variant of Frontotemporal Disorder (bvFTD)
- +3 more
- Submission of the NEO-PI-3 questionnaire
- Submission of the Interpersonal Reactivity Index questionnaire (IRI)
- (no location specified)
Sep 29, 2023
Lianhua Qingwen in Treating Patients Infected With Omicron
Not yet recruiting
- COVID-19 Pneumonia
- The group of patients who received Lianhua Qingwen orally
- The group of patients who did not receive Lianhua Qingwen orally
- (no location specified)
Mar 20, 2023
Lung Diseases, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactant Trial in Saint Louis
Recruiting
- Lung Diseases
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Prophylaxis of Deep Vein Thrombosis Trial in Alexandria (r-Hirudin)
Recruiting
- Prophylaxis of Deep Vein Thrombosis
-
Alexandria, EgyptAlexandria University
Apr 26, 2023
Myopia Trial in Hung Hom (Variant of Defocus Incorporated Spectacle lens (DG2))
Not yet recruiting
- Myopia
- Variant of Defocus Incorporated Spectacle lens (DG2)
-
Hung Hom, Hong KongSchool of Optometry, The Hong Kong Polytechnic University
May 24, 2023
Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T
Not yet recruiting
- Recurrent Glioblastoma
- Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
- (no location specified)
Apr 4, 2023
Covid19 Trial in Australia (SII B.1.351, SII Bivalent, SII B.1.617.2)
Withdrawn
- Covid19
- SII B.1.351
- +2 more
-
Maroubra, New South Wales, Australia
- +3 more
May 25, 2022
SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 variant mRNA vaccine low dose
- SARS-CoV-2 variant mRNA vaccine high dose
- (no location specified)
Oct 30, 2022
Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Ursodeoxycholic acid (UDCA) 500 mg)
Recruiting
- Rheumatoid Arthritis
- Placebo
- Ursodeoxycholic acid (UDCA) 500 mg
-
Shibīn Al Kawm, EgyptMenoufia University Hospital
Aug 1, 2023
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative
Not yet recruiting
- Inherited Cancer Syndrome
- +4 more
- Correlative Studies (Survey)
- +4 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 5, 2022
Breast Cancer Trial in Drammen (Polygenetic risk score)
Recruiting
- Breast Cancer
- Polygenetic risk score
-
Drammen, NorwayVestre Viken Hospital Trust
Feb 16, 2023
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
- +2 more
- (no location specified)
Dec 1, 2022
Sepsis, Pre-Eclampsia, Granulomatosis With Polyangiitis Trial in Münster (Procalcitonin-variants ELISA-Assay)
Recruiting
- Sepsis
- +6 more
- Procalcitonin-variants ELISA-Assay
-
Münster, North Rhine-Westphalia, GermanyUniversity Hospital Münster
Jan 19, 2023
SMN Circular RNAs as Potential Biomarkers for Therapeutic
Recruiting
- Spinal Muscular Atrophy
-
Rome, Italy/rome, Italyethics committee of IRCCS Fondazione Policlinico Gemelli
Mar 10, 2023
Prostate Cancer Trial in Fort-de-France (HOXB13 c.853delT mutation)
Recruiting
- Prostate Cancer
- HOXB13 c.853delT mutation
-
Fort-de-France, MartiniqueCentre Hospitalier Universitaire de Martinique
Aug 3, 2022